↓ Skip to main content

The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice

Overview of attention for article published in Psychopharmacology, October 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent
2 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
56 Mendeley
Title
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice
Published in
Psychopharmacology, October 2006
DOI 10.1007/s00213-006-0568-z
Pubmed ID
Authors

R. L. Rabenstein, B. J. Caldarone, M. R. Picciotto

Abstract

Increases in cholinergic transmission are linked to depression in human subjects and animal models. We therefore examined the effect of decreasing nicotinic acetylcholine receptor (nAChR) activity in tests of antidepressant efficacy using C57BL/6J mice.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
United Kingdom 1 2%
Czechia 1 2%
Unknown 52 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 16%
Student > Master 9 16%
Student > Bachelor 9 16%
Researcher 7 13%
Student > Doctoral Student 5 9%
Other 11 20%
Unknown 6 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 15 27%
Neuroscience 12 21%
Medicine and Dentistry 7 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Psychology 2 4%
Other 5 9%
Unknown 11 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2023.
All research outputs
#3,511,880
of 23,943,619 outputs
Outputs from Psychopharmacology
#875
of 5,456 outputs
Outputs of similar age
#7,670
of 69,244 outputs
Outputs of similar age from Psychopharmacology
#12
of 47 outputs
Altmetric has tracked 23,943,619 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,456 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,244 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.